Lemtrada(R) approved in Mexico for treatment of MS
Posted: Tue Feb 04, 2014 8:19 am
Genzyme, a Sanofi company, announced today that Mexico's national regulatory authority, COFEPRIS, has approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing remitting forms of multiple sclerosis (MS) to slow or reverse the accumulation of physical disability and reduce the frequency of clinical exacerbations..... Read More - http://www.ms-uk.org/lemtrada